Ayuso M A, Luis M, Sala X, Martínez G, Sánchez J, Alarcón A
Departamento de Anestesiología y Reanimación, Hospital Clínic i Provincial, Barcelona.
Rev Esp Anestesiol Reanim. 1997 Jan;44(1):7-12.
To study high frequency jet ventilation (HFJV) in patients with chronic obstructive pulmonary disease (COPD) who are obese or who have tracheal or laryngeal stenosis, conditions which are often found in patients undergoing microsurgery of the larynx (MSL), comparing the results with those for a group of controls, patients with no stenosis who were also undergoing MSL.
Eighty patients were distributed in four groups as follows: those meeting the criteria for a diagnosis of COPD (n = 20), those who were overweight (n = 24), those with stenosis over 50% of the laryngeal opening (stenosis group, n = 10) and those with no associated pathology (control group, n = 26). HFJV was administered through a 2.2 mm internal diameter orotracheal injection catheter, using an Ergojet CVT (Temel, S.A.). The ventilatory protocol was as follows: rate 100 breaths/min, inspiratory time 30%, generator pressure (GP) 2.2 to 3.3 kg/cm2 and FiO2 70% to 90%. We analyzed the GP administered, jet volume (Vjet) delivered, maximum (PAWmax) and minimum (PAWmin) airway pressures, oxygen hemoglobin saturation (SpO2), partial pressures of O2 (pO2) and CO2 (pCO2) in arterial blood, and end-tidal pressure of CO2 (PETCO2) at baseline and 10 and 20 min after the start of HFJV. Because monitoring was invasive, the study was designed for a small series of patients and we believe it should not be generalized to include all patients undergoing MSL under normal conditions.
HFJV had to be abandoned and conventional ventilation used in 4 patients (2 in the COPD group and 2 in the obese group). Ventilation was judged adequate in the remaining patients, with the observations that in the COPD group, pO2 levels were lower than in the control group at the 10 min readings and pCO2 levels were higher at both the 10 and 20 min readings. PAW levels were higher throughout the procedure in both the COPD and stenosis groups. In the obese patients, pCO2 was higher at both the 10 and 20 min recordings.
HFJV provides effective ventilation for most patients undergoing MSL, even if they are obese or have COPD or laryngeal stenosis.
研究高频喷射通气(HFJV)在患有慢性阻塞性肺疾病(COPD)、肥胖或存在气管或喉狭窄的患者中的应用情况,这些情况在接受喉显微手术(MSL)的患者中较为常见,并将结果与一组对照组(同样接受MSL但无狭窄的患者)进行比较。
80例患者分为四组如下:符合COPD诊断标准的患者(n = 20)、超重患者(n = 24)、喉口狭窄超过50%的患者(狭窄组,n = 10)以及无相关病变的患者(对照组,n = 26)。使用Ergojet CVT(Temel, S.A.)通过内径为2.2 mm的经口气管注射导管进行HFJV。通气方案如下:频率100次/分钟,吸气时间30%,发生器压力(GP)2.2至3.3 kg/cm²,吸入氧浓度(FiO₂)70%至90%。我们分析了基线时以及HFJV开始后10分钟和20分钟时给予的GP、输送的喷射气量(Vjet)、气道最大(PAWmax)和最小(PAWmin)压力、氧血红蛋白饱和度(SpO₂)、动脉血中氧分压(pO₂)和二氧化碳分压(pCO₂)以及呼气末二氧化碳分压(PETCO₂)。由于监测具有侵入性,该研究针对一小部分患者设计,我们认为不应将其推广至所有在正常情况下接受MSL的患者。
4例患者(COPD组和肥胖组各2例)不得不放弃HFJV而采用传统通气。其余患者通气情况被判定为充分,观察发现,在COPD组中,10分钟读数时的pO₂水平低于对照组,10分钟和20分钟读数时的pCO₂水平均较高。在整个过程中,COPD组和狭窄组的PAW水平均较高。在肥胖患者中,10分钟和20分钟记录时的pCO₂均较高。
HFJV为大多数接受MSL的患者提供了有效的通气,即使他们肥胖或患有COPD或喉狭窄。